PUBLISHER: TechNavio | PRODUCT CODE: 1516327
PUBLISHER: TechNavio | PRODUCT CODE: 1516327
The atrial fibrillation surgery market is forecasted to grow by USD 1993.8 mn during 2023-2028, accelerating at a CAGR of 14.76% during the forecast period. The report on the atrial fibrillation surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advances in technology, minimally invasive procedures with improved medical imaging, and increased prevalence of arrhythmia.
Technavio's atrial fibrillation surgery market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 12.55% |
CAGR | 14.76% |
Incremental Value | $1993.8mn |
By Product
By Geography
This study identifies the emergence of digital catheterization labs in hospitals as one of the prime reasons driving the atrial fibrillation surgery market growth during the next few years. Also, marketing and sales strategies and development of robot-assisted navigation technologies will lead to sizable demand in the market.
The report on the atrial fibrillation surgery market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading atrial fibrillation surgery market vendors that include Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Avanos Medical Inc., BIOTRONIK SE and Co. KG, Boehringer Ingelheim International GmbH, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson Services Inc., Koninklijke Philips N.V., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., OSYPKA AG, Siemens Healthineers AG, Stereotaxis Inc., Teleflex Inc., and Tempus Labs Inc.. Also, the atrial fibrillation surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: